Literature DB >> 6436862

Cholinergic learning deficits in the marmoset produced by scopolamine and ICV hemicholinium.

R M Ridley, N G Barratt, H F Baker.   

Abstract

Common marmosets (Callithrix jacchus) were trained to perform daily position discrimination learning tasks in a Wisconsin General Test Apparatus. Acetylcholine receptor blockade with scopolamine was found to impair position learning. Testing on the day after scopolamine treatment suggested that a task learnt under scopolamine was not encoded into long term memory. Acetylcholine depletion achieved by the intraventricular injection of hemicholinium 4 h before testing resulted in a profound impairment of position discrimination learning. It is suggested that central acetylcholine depletion in primates may provide a useful model of senile dementia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6436862     DOI: 10.1007/bf00428542

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  STATE-DEPENDENT OR "DISSOCIATED" LEARNING PRODUCED WITH PENTOBARBITAL.

Authors:  D A OVERTON
Journal:  J Comp Physiol Psychol       Date:  1964-02

2.  Discrimination reversal learning in marmosets.

Authors:  T E COTTERMAN; D R MEYER; D D WICKENS
Journal:  J Comp Physiol Psychol       Date:  1956-12

3.  Learning sets in marmosets.

Authors:  R C MILES; D R MEYER
Journal:  J Comp Physiol Psychol       Date:  1956-06

4.  Food deprivation and discrimination reversal learning by monkeys.

Authors:  D R MEYER
Journal:  J Exp Psychol       Date:  1951-01

5.  High affinity transport of choline into synaptosomes of rat brain.

Authors:  H I Yamamura; S H Snyder
Journal:  J Neurochem       Date:  1973-12       Impact factor: 5.372

Review 6.  The central effects of scopolamine in man.

Authors:  D J Safer; R P Allen
Journal:  Biol Psychiatry       Date:  1971       Impact factor: 13.382

7.  Short-term memory in the rhesus monkey: disruption from the anti-cholinergic scopolamine.

Authors:  R T Bartus; H R Johnson
Journal:  Pharmacol Biochem Behav       Date:  1976-07       Impact factor: 3.533

8.  Necropsy evidence of central cholinergic deficits in senile dementia.

Authors:  E K Perry; R H Perry; G Blessed; B E Tomlinson
Journal:  Lancet       Date:  1977-01-22       Impact factor: 79.321

9.  Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains.

Authors:  P Davies; A H Verth
Journal:  Brain Res       Date:  1977-12-16       Impact factor: 3.252

10.  Memory and cognitive function in man: does the cholinergic system have a specific role?

Authors:  D A Drachman
Journal:  Neurology       Date:  1977-08       Impact factor: 9.910

View more
  11 in total

1.  Forebrain deletion of the vesicular acetylcholine transporter results in deficits in executive function, metabolic, and RNA splicing abnormalities in the prefrontal cortex.

Authors:  Benjamin Kolisnyk; Mohammed A Al-Onaizi; Pedro H F Hirata; Monica S Guzman; Simona Nikolova; Shahar Barbash; Hermona Soreq; Robert Bartha; Marco A M Prado; Vania F Prado
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

2.  Post-retrieval effects of icv infusions of hemicholinium in mice are dependent on the age of the original memory.

Authors:  Mariano M Boccia; Mariano G Blake; Gabriela B Acosta; Carlos M Baratti
Journal:  Learn Mem       Date:  2006 May-Jun       Impact factor: 2.460

3.  Proceedings of the British Pharmacological Society Meeting. Sheffield, 18-20th April 1990.

Authors: 
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

4.  Effects of arecoline and pilocarpine on learning ability in marmosets pretreated with hemicholinium-3.

Authors:  R M Ridley; H F Baker; B Drewett
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Effects of disrupting the cholinergic system on short-term spatial memory in rats.

Authors:  J S Andrews; J H Jansen; S Linders; A Princen
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

6.  Therapeutic effect of THA on hemicholinium-3-induced learning impairment is independent of serotonergic and noradrenergic systems.

Authors:  J J Hagan; J H Jansen; F E Nefkens; T de Boer
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Effects of ibotenic acid lesions of the basal forebrain on serial reversal learning in marmosets.

Authors:  R M Ridley; H F Baker; B Drewett; J A Johnson
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Hemicholinium-3 impairs spatial learning and the deficit is reversed by cholinomimetics.

Authors:  J J Hagan; J H Jansen; C L Broekkamp
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

9.  The neurotrophins and their role in Alzheimer's disease.

Authors:  Shelley J Allen; Judy J Watson; David Dawbarn
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363

Review 10.  Alzheimer's disease and stem cell therapy.

Authors:  Sung S Choi; Sang-Rae Lee; Seung U Kim; Hong J Lee
Journal:  Exp Neurobiol       Date:  2014-03-27       Impact factor: 3.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.